275 related articles for article (PubMed ID: 28516725)
61. Increased Risk of Herpes Zoster in Young and Metabolically Healthy Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study.
Soh H; Chun J; Han K; Park S; Choi G; Kim J; Lee J; Im JP; Kim JS
Gut Liver; 2019 May; 13(3):333-341. PubMed ID: 30602222
[TBL] [Abstract][Full Text] [Related]
62. Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.
Belle A; Baumann C; Bigard MA; Zallot C; Gizard E; Guéant JL; Bronowicki JP; Peyrin-Biroulet L
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):877-81. PubMed ID: 26121376
[TBL] [Abstract][Full Text] [Related]
63. Severe perianal shingles during azathioprine and budesonide treatment for Crohn's disease-preventable with zoster vaccine?
Elliott TR; Miller C; Macrae FA
BMJ Case Rep; 2016 Jul; 2016():. PubMed ID: 27440857
[TBL] [Abstract][Full Text] [Related]
64. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.
Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY
J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400
[TBL] [Abstract][Full Text] [Related]
65. Zoster vaccine live.
Kockler DR; McCarthy MW
Pharmacotherapy; 2007 Jul; 27(7):1013-9. PubMed ID: 17594207
[TBL] [Abstract][Full Text] [Related]
66. Herpes Zoster During Immunosuppressive Therapy For Autoimmune Diseases.
Zahid MF; Ghufran M; Mansoor AE; Sohail MR
J Ayub Med Coll Abbottabad; 2017; 29(3):481-485. PubMed ID: 29076688
[TBL] [Abstract][Full Text] [Related]
67. Increased Risk of Herpes Zoster Infection in Patients With Inflammatory Bowel Diseases in Korea.
Chang K; Lee HS; Kim YJ; Kim SO; Kim SH; Lee SH; Song EM; Hwang SW; Park SH; Yang DH; Ye BD; Byeon JS; Myung SJ; Yang SK
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1928-1936.e2. PubMed ID: 29857150
[TBL] [Abstract][Full Text] [Related]
68. [The clinical and epidemic characteristics of shingles (herpes zoster) and its prevention with vaccines].
Afonina NM; Mikheeva IV
Ter Arkh; 2013; 85(11):130-3. PubMed ID: 24432613
[TBL] [Abstract][Full Text] [Related]
69. Shoulder pain due to cervical radiculopathy: an underestimated long-term complication of herpes zoster virus reactivation?
Gumina S; Candela V; Passaretti D; Villani C
Int Orthop; 2018 Jan; 42(1):157-160. PubMed ID: 28798978
[TBL] [Abstract][Full Text] [Related]
70. Systematic review with network meta-analysis: Risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel disease.
Din S; Selinger CP; Black CJ; Ford AC
Aliment Pharmacol Ther; 2023 Mar; 57(6):666-675. PubMed ID: 36585944
[TBL] [Abstract][Full Text] [Related]
71. Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease.
Khan N; Trivedi C; Aberra F; Pernes T; Yang YX
J Crohns Colitis; 2022 Sep; 16(9):1505-1507. PubMed ID: 35350070
[TBL] [Abstract][Full Text] [Related]
72. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination.
Civen R; Chaves SS; Jumaan A; Wu H; Mascola L; Gargiullo P; Seward JF
Pediatr Infect Dis J; 2009 Nov; 28(11):954-9. PubMed ID: 19536039
[TBL] [Abstract][Full Text] [Related]
73. Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New?
Reich JS; Farraye FA; Wasan SK
Dig Dis Sci; 2016 Aug; 61(8):2205-2216. PubMed ID: 27061291
[TBL] [Abstract][Full Text] [Related]
74. Increased incidence of systemic serious viral infections in patients with inflammatory bowel disease associates with active disease and use of thiopurines.
Wisniewski A; Kirchgesner J; Seksik P; Landman C; Bourrier A; Nion-Larmurier I; Marteau P; Cosnes J; Sokol H; Beaugerie L;
United European Gastroenterol J; 2020 Apr; 8(3):303-313. PubMed ID: 32529821
[TBL] [Abstract][Full Text] [Related]
75. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.
Wood SM; Shah SS; Steenhoff AP; Rutstein RM
Pediatrics; 2008 Jan; 121(1):e150-6. PubMed ID: 18086820
[TBL] [Abstract][Full Text] [Related]
76. The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013.
Hobbelen PH; Stowe J; Amirthalingam G; Miller L; van Hoek AJ
J Infect; 2016 Sep; 73(3):241-53. PubMed ID: 27283754
[TBL] [Abstract][Full Text] [Related]
77. Vaccination Reduces Risk of Alzheimer's Disease, Parkinson's Disease and Other Neurodegenerative Disorders.
Lehrer S; Rheinstein PH
Discov Med; 2022; 34(172):97-101. PubMed ID: 36281030
[TBL] [Abstract][Full Text] [Related]
78. Incidence of herpes zoster among patients with hidradenitis suppurativa: A retrospective population-based cohort analysis.
Wertenteil S; Strunk A; Garg A
J Am Acad Dermatol; 2018 Dec; 79(6):1162-1163. PubMed ID: 30092323
[No Abstract] [Full Text] [Related]
79. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Pellissier JM; Brisson M; Levin MJ
Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
[TBL] [Abstract][Full Text] [Related]
80. Risk of zoster in patients on immunosuppressant therapy: evaluation of current data.
Tafuri SS; Chironna MM; Quarto MM; Germinario CC
Am J Infect Control; 2015 Apr; 43(4):420-1. PubMed ID: 25690878
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
